Literature DB >> 21418542

Marked discrepancy between coagulometric protein C activity assays with the pro-thrombotic protein C Asn2Ile substitution.

P C Cooper1, S Siddiq, C Morse, J Nightingale, A D Mumford.   

Abstract

INTRODUCTION: Protein C (PC) Asn2Ile is a rare pro-thrombotic variant in which loss of anticoagulant function in vivo is likely to result from defective PC binding to the endothelial PC receptor and phospholipid.
METHODS: To characterize the consequences of this functional defect on the diagnostic performance of commercial PC activity assays, we performed one antigen, three chromogenic and three coagulometric assays on plasma from a subject who was heterozygous for the PC Asn2Ile substitution.
RESULTS: As anticipated, the PC antigen (96.2 IU/dl) and chromogenic PC activity assays (98.4 IU/dl) were insensitive to PC Asn2Ile, which has intact enzymatic activity and is secreted normally. There was a marked reduction in apparent PC activity by STACLOT coagulometric assay (50.4 IU/dl). However, there was only a small reduction in apparent PC activity by CRYOcheck Clot C assay (69.5 IU/dl) and by HemosIL ProClot assay, the PC activity was within the laboratory reference range (91 IU/dl). This discrepancy between coagulometric assays could not be explained by lupus anticoagulant, activated PC resistance or elevated plasma factor VIII activity.
CONCLUSION: We demonstrate that coagulometric assays are not equally sensitive to clinically important functional defects of PC and that multiple assays may be required to identify all variants.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418542     DOI: 10.1111/j.1751-553X.2011.01311.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  3 in total

1.  Laboratory Limitations of Excluding Hereditary Protein C Deficiency by Chromogenic Assay: Discrepancies of Phenotype and Genotype.

Authors:  Holger Seidel; Bianca Haracska; Jennifer Naumann; Philipp Westhofen; Moritz Sebastian Hass; Johannes Philipp Kruppenbacher
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

2.  Deficiencies of the Natural Anticoagulants - Novel Clinical Laboratory Aspects of Thrombophilia Testing.

Authors:  Zsuzsanna Bereczky; Réka Gindele; Marianna Speker; Judit Kállai
Journal:  EJIFCC       Date:  2016-04-20

3.  Comparison of clot-based and chromogenic assay for the determination of protein c activity.

Authors:  Tariq M Roshan; Nancy Stein; Xiu Y Jiang
Journal:  Blood Coagul Fibrinolysis       Date:  2019-06       Impact factor: 1.276

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.